Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value ($000): $2,642,256 (100.0% shares, 0.0% debt)

Holdings (8)

MRNA MODERNA INC 45.3%

Value ($000) $1,196,730 Shares 58,807,379 Est. Cost $16.43 Unrealized +12.9%

— RUBIUS THERAPEUTICS INC 26.2%

Value ($000) $693,167 Shares 38,296,526 Est. Cost $24.00 Unrealized —

KLDO KALEIDO BIOSCIENCES INC 9.5%

Value ($000) $251,731 Shares 17,360,710 Est. Cost $13.76 Unrealized 0.0%

DNLI DENALI THERAPEUTICS INC 7.0%

Value ($000) $185,893 Shares 8,005,747 Est. Cost $17.97 Unrealized +16.4%

— EVELO BIOSCIENCES INC 5.5%

Value ($000) $145,867 Shares 18,233,403 Est. Cost $11.80 Unrealized —

— SERES THERAPEUTICS INC 3.3%

Value ($000) $87,131 Shares 12,682,876 Est. Cost $12.29 Unrealized —

QTRX QUANTERIX CORP 2.0%

Value ($000) $52,448 Shares 2,030,495 Est. Cost $19.52 Unrealized +14.4%

— SYROS PHARMACEUTICALS INC 1.1%

Value ($000) $29,289 Shares 3,204,437 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	MODERNA INC	58,807,379	$1,196,730	45.3%	$16.43	+12.9%	COM	60770K107
—	RUBIUS THERAPEUTICS INC	38,296,526	$693,167	26.2%	$24.00	—	COM	78116T103
KLDO	KALEIDO BIOSCIENCES INC	17,360,710	$251,731	9.5%	$13.76	0.0%	COM	483347100
DNLI	DENALI THERAPEUTICS INC	8,005,747	$185,893	7.0%	$17.97	+16.4%	COM	24823R105
—	EVELO BIOSCIENCES INC	18,233,403	$145,867	5.5%	$11.80	—	COM	299734103
—	SERES THERAPEUTICS INC	12,682,876	$87,131	3.3%	$12.29	—	COM	81750R102
QTRX	QUANTERIX CORP	2,030,495	$52,448	2.0%	$19.52	+14.4%	COM	74766Q101
—	SYROS PHARMACEUTICALS INC	3,204,437	$29,289	1.1%	$13.87	—	COM	87184Q107